Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A OTT

Showing results (581-590 of 667) with videos related to

Pageof 67
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2021
Long-term Overall Survival and Predictors in Anti-PD-1-naive Melanoma Patients With Brain Metastases Treated With Immune Checkpoint Inhibitors in the Real-world Setting: A Multicohort StudyGirish S Naik, Elizabeth I Buchbinder, Justine V Cohen, et al.
AIDS (London, England)|September 26, 2025
Ethical considerations for research involving pregnant women with HIV and their childrenMegan S McHenry, Eric R Masese, Daniel Kinyanjui, et al.
Cancer Cell|June 14, 2022
Cancer vaccinesJohn T Schiller, Douglas R Lowy, Ian H Frazer, et al.
Nature Communications|November 10, 2021
Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disordersLuca Pagliaroli, Patrizia Porazzi, Alyxandra T Curtis, et al.
Nature Communications|November 5, 2025
Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma modelsConnor A Ott, Timothy J Purwin, Pan-Yu Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2018
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric CancerYelena Y Janjigian, Johanna Bendell, Emiliano Calvo, et al.
Epidemiology and Infection|October 30, 2020
Seroprevalences of antibodies against ToRCH infectious pathogens in women of childbearing age residing in Brazil, Mexico, Germany, Poland, Turkey and ChinaJ M Warnecke, M Pollmann, V Borchardt-Lohölter, et al.
Cancer Immunology Research|October 29, 2017
Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition TherapyHyunju Lee, F Stephen Hodi, Anita Giobbie-Hurder, et al.
Journal for Immunotherapy of Cancer|November 13, 2021
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trialPatrick A Ott, Matthew Nazzaro, Kathleen L Pfaff, et al.
The Journal of Pediatrics|November 19, 2022
Capacity to Consent to Research Among Adolescent-Parent Dyads in Rakai, UgandaPhilip Kreniske, Susie Hoffman, William Ddaaki, et al.
Pageof 67

Showing results (581-590 of 667) with videos related to

Sort By:
Pageof 67
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2021
Long-term Overall Survival and Predictors in Anti-PD-1-naive Melanoma Patients With Brain Metastases Treated With Immune Checkpoint Inhibitors in the Real-world Setting: A Multicohort StudyGirish S Naik, Elizabeth I Buchbinder, Justine V Cohen, et al.
AIDS (London, England)|September 26, 2025
Ethical considerations for research involving pregnant women with HIV and their childrenMegan S McHenry, Eric R Masese, Daniel Kinyanjui, et al.
Cancer Cell|June 14, 2022
Cancer vaccinesJohn T Schiller, Douglas R Lowy, Ian H Frazer, et al.
Nature Communications|November 10, 2021
Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disordersLuca Pagliaroli, Patrizia Porazzi, Alyxandra T Curtis, et al.
Nature Communications|November 5, 2025
Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma modelsConnor A Ott, Timothy J Purwin, Pan-Yu Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2018
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric CancerYelena Y Janjigian, Johanna Bendell, Emiliano Calvo, et al.
Epidemiology and Infection|October 30, 2020
Seroprevalences of antibodies against ToRCH infectious pathogens in women of childbearing age residing in Brazil, Mexico, Germany, Poland, Turkey and ChinaJ M Warnecke, M Pollmann, V Borchardt-Lohölter, et al.
Cancer Immunology Research|October 29, 2017
Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition TherapyHyunju Lee, F Stephen Hodi, Anita Giobbie-Hurder, et al.
Journal for Immunotherapy of Cancer|November 13, 2021
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trialPatrick A Ott, Matthew Nazzaro, Kathleen L Pfaff, et al.
The Journal of Pediatrics|November 19, 2022
Capacity to Consent to Research Among Adolescent-Parent Dyads in Rakai, UgandaPhilip Kreniske, Susie Hoffman, William Ddaaki, et al.
Pageof 67